A patient with type 2 diabetes on metformin is started on a sulfonylurea. He presents 3 hours after a meal with sweating, tremors and a blood glucose of 42 mg/dL. Which sulfonylurea is MOST likely to cause this prolonged hypoglycaemia?
- A Glipizide
- B Glibenclamide (Glyburide) ✓
- C Tolbutamide
- D Gliclazide
Explanation
Glibenclamide (glyburide) is a second-generation sulfonylurea with the longest half-life (~10 hours) among commonly used agents, and its active metabolites further prolong hypoglycaemia. It strongly closes pancreatic beta-cell KATP channels independent of glucose concentration. Tolbutamide has the shortest half-life (~4-6 hours) and is the safest in elderly patients. Glipizide and gliclazide have intermediate durations and are safer in renal impairment.
Reference: KD Tripathi, Essentials of Medical Pharmacology, 8th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.